{"slideshow_credits": null, "snippet": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2016/06/03/business/dealbook/johnson-johnson-is-urged-to-slim-down.html", "lead_paragraph": "The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.", "headline": {"main": "Johnson &amp; Johnson Is Urged to Slim Down", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "57509af838f0d86ce33330ac", "word_count": "388", "multimedia": [], "pub_date": "2016-06-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Eli Lilly and Company", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Johnson & Johnson", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Abbott Laboratories", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Medical Devices", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}